The CogNaive Study: Assessing Changes in Neurocognitive Function in Treatment Naïve HIV-1 Positive Subjects

NCT00540137 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: nevirapine
DRUG: atazanavir/ritonavir

Sponsor

Imperial College London

Collaborators

[object Object]